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ABSTRACT 
 
 
  
              Nanoparticles prepared from whey protein isolates can be used for 
encapsulation and sustained delivery of β-carotene and zinc (II) ions. The 
loaded whey protein nanoparticles were prepared by the pH cycle method at 
aggregation pH 6 and 22 h ageing time in the presence of calcium ions. 
Morphology, particle size, stability and release profiles at neutral and acidic 
conditions of the loaded whey protein nanoparticles were evaluated. The 
results illustrated that whey protein nanoparticles were able to encapsulate β-
carotene molecules in spherical compact structures of around 400 nm that 
can protect sensitive β-carotene and limit its susceptibility to auto-oxidation 
reactions when compared to control samples. Moreover, Whey protein 
nanoparticles showed higher release profiles at neutral conditions compared 
to acidic conditions even in the presence of proteo-lytic enzymes. These 
findings confirmed that whey protein nanoparticles can be used to 
encapsulate, protect and enhance the release profile of sensitive biological 
active ingredients and micronutrients to be used for food as well as 
pharmaceutical applications. 
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Chapter 1: Introduction 
1.1. Whey protein 
1.1.1. Overview 
Milk Constituents have recently started to be considered functional foods 
due to their beneficial effects on the human body. Among these constituents, 
“whey” has been recognized as one of the most nutritious and valuable milk 
components. By definition, whey is the liquid by-product produced during 
cheese-making and casein manufacture in the dairy industry. It was 
discovered about 3000 years ago when the stomachs of calves were used to 
store and transport milk. During this period, the enzyme Chymosin (rennet) 
that was naturally present in the cell lining of calves’ stomachs, caused  milk 
coagulation, leading to the formation of a solid mass (i.e. curd), while 
“whey” was the remaining liquid [1].  Historically, whey was considered a 
waste by cheese-makers and casein manufacturers and they tried different 
approaches for disposing of it, like discharging into lakes or rivers, spraying 
onto fields, discharging into the municipal sewage system or selling it as 
animal feed.[1] All the previous methods were based on the fact that cheese 
manufacturer believed that whey is a waste product with little value, and that 
it should be disposed of by the most economical methods. However, 
disposing of very high amounts of whey by these methods raised different 
environmental considerations due to the very high BOD value (i.e. 175-fold 
higher than normal sewage) of whey (Biochemical oxygen demand (BOD) is 
the amount of dissolved oxygen required by aerobic organisms to break 
down organic material present in a given water sample at certain temperature 
over a specific time period. It is important as it is one of the parameters that 
assess the water quality)[2], therefore different countries started to put 
tighter restrictions on whey disposal methods.[1] 
There are two main types of whey, there is sweet whey and acidic whey, and 
they differ in the manufacturing process. As sweet whey is produced Sweet 
whey is manufactured during the making of rennet types of hard cheese like 
Swiss cheese or cheddar. While Acid whey is a liquid by-product produced 
during the making of acid types of dairy products like cottage cheese or 
strained yogurt. [3] 
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Within this context, manufacturers started to work on different whey-
processing techniques to benefit from it and at the same time limit down its 
environmental hazard. These techniques involve cost-effective and efficient 
unit processes for concentration, conversion, fractionation and dehydration 
of whey, along with the invention of new biochemical technologies for the 
production of new high value whey-based ingredients as nutraceuticals or 
functional foods for different food industrial applications. [1] 
This breakthrough in whey protein utilization was driven by the full 
understanding of its chemical, physical, biological and nutritional properties.  
1.1.2. Composition: 
Whey powder contains highly nutritious components like biologically active 
proteins (i.e. alpha-Iactalbumin (ALA), beta-lactoglobulin (BLG), bovine 
serum albumin (BSA), immune-globulins (IgG)), also, there are some 
minors proteins like macro-glycopeptides, lactoferrin and lacto peroxidase 
along with other significant amount of vitamins, minerals and fats. Among 
these components, whey proteins are recognized as the most valuable, 
constituting about 20% of the whole protein content of milk, while casein 
accounts for the remainder. [4] Table 1-1. Shows the total composition of 
whey;  
Table1-1. Typical composition for Whey powder [5] 
Total solids  96-97% 
Lactose 70-75% 
Total protein  
(N x 6.38) 
10-13% 
Minerals 
Ash 7-12% 
Calcium 4500 mg/kg 
Vitamins 
Thiamine 0.4-0.6 mg 
Riboflavin 2.3-2.5 mg 
Pyridoxine 0.4-0.6 mg 
 
Indeed, whole protein content presents in whey constitutes about 20% of the 
whole protein content of milk, and they are responsible for the outstanding 
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attributes of whey. Nowadays, whey is considered a popular dietary protein 
supplement that is supposed to provide immune modulation, antimicrobial 
activity, improved muscle strength and, and prevention of osteoporosis and 
cardiovascular disease.[6][7]  
Protein content 
All the protein components present in whey powder provide high levels of 
essential and branched chain amino acids (BCAA); at the same time, they 
provide some pharmacological activities that are beneficial to human being.  
Table 1-2 presents the functions and abundance of different types of protein 
present in whey:  
Table 1-2. Individual whey proteins and their functions and average 
concentration [7] 
Protein Function Average 
concentration 
beta-Lactoglobulin 
 
 Binds fat soluble vitamins 
(K,E,D,A), to enhance their 
bioavailability 
 Essential and branched chain amino 
acids source. 
 Spares glycogen and muscle during 
heavy exercises 
50-55% 
 
alpha-Lactalbumin 
 
 Rich in the essential amino acid 
tryptophan that aids in regulating 
sleep, stress and mood. 
 Main protein present in human 
breast milk 
 Essential and branched chain amino 
acids source. 
20-25% 
 
lmmunoglobulins 
 
 Group of proteins (i.e. IgA. IgO, 
IgE. IgG, IgM and IgG) that are 
produced by blood plasma cells to 
help the immune system in 
identifying and deactivating foreign 
organisms like bacteria and viruses. 
10-15% 
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 Enhances the performance of 
immunity system. 
 
Glyco-macropeptide  Free from the amino acid 
phenylalanine, so it is suitable for 
infants with phenylketonuria (It is a 
genetic metabolic disorder that 
prevents the body from 
metabolizing the phenylalanine 
(Phe) amino acid, leading to its 
accumulation in then converted to 
phenylketone) 
 Prevents dental plaque and cavities` 
formation 
10-15% 
 
Bovine Serum Albumin  Large protein that contain high 
amount of essential amino acids  
 Fat binding properties  
 
5-10% 
 
Lacto-ferrin 
 
 Acts as antioxidant in breast milk, 
saliva, tears and blood 
 Antibacterial, antiviral, antifungal 
 Stimulates the growth of gut flora 
(beneficial bacteria) 
 Enhances iron bioavailability 
 
1-2% 
 
Lacto-peroxidase 
 
 Inhibits bacterial growth  0.5% 
 
 
There are three major types of whey protein; concentrate (WPC), isolate 
(WPI), and hydro-lysate (WPH). Both forms, isolate and hydro-lysate, are 
advanced formulas derived from the whey protein concentrate after 
additional processing steps. These steps result in products that differ from 
whey concentrate in many important characteristics. Table 1-3, shows the 
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percentage of protein in each type; where whey protein concentrate has 
around 29%–89% protein by weight and low level of cholesterol and fat, 
however, it has higher levels of lactose and other bioactive compounds when 
compared with the other formulas.  
On the other hand, whey protein isolate contains more than 90% protein by 
weight, as it is subjected to further purifying steps to eliminate the lactose, 
cholesterol and fat in order to maximize the protein yield.[8] 
 
Table 1-3. Percent composition of different types of whey protein 
products[8]; 
Component Whey Powder Whey Concentrate Whey Isolate 
Protein  11 – 14.5 28 – 89 90 + 
Lactose 63 – 75 10 – 55 0.5 
Milk Fat 1 – 1.5 2 – 10 0.5 
 
The third type of whey protein is the whey protein hydro-lysates which are 
partially hydrolyzed by exposing the protein to acid, heat, or enzymes that 
break apart the bonds between amino acids. This makes this type of proteins 
are more absorbable than a concentrate or isolate. [9]  
 
1.1.3. Processing 
Commercially, sweet whey is produced during the cheese-making process 
when fluid milk, that contains caseins and whey proteins, is turned into 
cheese after the addition of specific enzymes and bacteria. These bacteria 
metabolize the milk lactose to generate lactic acid. This lactic acid decreases 
the milk pH value from 6.7 to around 5.3, which causes the coagulation of 
casein proteins.  The whey proteins don’t denature (a process in which 
proteins lose the quaternary, tertiary and secondary structures which is 
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present in their original form) at this pH level due to their unique structure, 
but they get trapped within the casein gel that forms. Cheese producers 
introduce perforation into this gel In order to release most of the whey and 
accompanying proteins from the casein curd, the whey is then drained from 
the curd and gets utilized into a variety of ingredients.  
During cheese manufacturing approximately 90% by volume of the entered 
liquid milk to the plant is converted to whey. And the most profitable 
solution for the ecological problem caused by whey is to reuse it in other 
pharmaceutical and food applications. Thus, cost-effective processing of the 
whey is very importance to the economics of cheese manufacture, because 
the cost of whey disposal may reach £200 per ton (2006).[10] 
Any cheese factory that produces more than 300m3 per day of whey can 
process whey commercially. For other dairy manufacturers who do not 
produce this volume of scale, it is common to pre-concentrate the whey at 
the cheese factory and transport it for downstream processing in a dedicated 
facility.[10] 
There are three main ways of whey processing, lactose production, animal 
feed-stocks and the production of whey powders and individual whey 
proteins [11]. 
Figure 1-1. shows the industrial processing of whey. Very long treatment of 
whey at average temperatures, ranging from  55°C to 63°C, and at certain 
stages of industrial vacuum evaporators the temperature may reach 70°C, can 
cause whey protein denaturation. However, applying the low-temperature 
methodology of vacuum concentration of whey at 20°C and ultrafiltration at 
50°C, preserves the natural structure of whey proteins in order to benefit 
from the bio-regulatory and physico-chemical effects of these products.[10] 
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Concentrated whey (45-65% d.w.) 
crystalline suspension of lactose 
Vacuum filter 
Whey from cheese manufacturing 
Vacuum Evaporation 
Lactose, Protein concentrate, 
minerals and residue 
Ultra-Dia-filteration (5-100,000 Dalton) 
Protein concentrate 
Vacuum Evaporation 
Condensed whey protein 
isolate or concentrate 
Lyophilization 
Dry whey protein concentrate 
or isolate  
Permeate 
Retenate: lactose solution 
Vacuum evaporation 
Lactose concentrate 
Dryer 
Mineral concentrate 
Vacuum evaporation 
Permeate: mineral solution 
Nano-filtration 
Dry food lactose 
Dryer 
Dry whey minerals 
Figure 1-1. Technology of whey processing into pharmaceutical and food products 
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1.1.4. Pharmacokinetics: 
Whey proteins exhibit a highly stable pharmacokinetic profile, as they do 
not coagulate under acidic environments and they can also resist the 
destructive action of enzyme Chymosin in the stomach.  Lacto-ferrin 
protein, for example, can survive the stomach acid without being denatured. 
However, whey proteins can reach the Jejunum quickly so they are 
considered to be "fast proteins,". After reaching the small intestine, they are 
hydrolyzed at a slow rate, even slower than that of casein, which allows 
greater percentage of protein to be absorbed over the whole length of the 
small intestine. Moreover, whey protein has higher postprandial level for 
plasma amino acids than casein. [7] 
1.1.5. Applications: 
Whey contains high levels of protein, vitamins and minerals, and is thus 
most recognized for its applicability in sports nutrition. Furthermore, whey 
products could also be used in baked goods, salad dressings, emulsifiers, and 
medical nutritional formulas. Moreover, Beta-lactoglobulin can be used in 
infants formulas.  
There are other innovative food and non-food applications for whey protein 
that could be attributed to its superior emulsification and gelling properties. 
β- Lactoglobulin is the most abundant protein and it has a very effective 
gelling property. Thus, whey protein gels could be used as pH-sensitive 
hydrogels (Hydrogel is a three-dimensional structure that has the ability to 
swell in water and retains a considerable amount of water within its 
network) for the controlled delivery of biologically-active substances [12]. 
1.2. Carotenoids 
1.2.1. Structure 
Carotenoids belong to the unsaturated hydrocarbons class with specific 
functional end groups and conjugated double bond system. Structurally, 
carotenoids may or may not have additional oxygen atoms attached. 
Carotenoids that contain oxygen are named xanthophylls (Figure 1-2) like 
lutein and zeaxanthin. However, α-carotene, β-carotene, and lycopene are 
the oxygen free carotenoinds (Figure 2).   
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 Figure 1-2 Xanthophylls (oxygenated carotenoid)[13] 
 
 
 
Figure 1-3 Carotene (oxygen free carotenoid)[13] 
Carotenoids can also be classified according to their provitamin A activity, 
where α-carotene, β-carotene, and β-cryptoxanthin, can be converted in the 
body to retinol and are thus classified as pro-vitamin A carotenoids. On the 
other hand, Lutein Lycopene, and zeaxanthin carotenoids have no vitamin A 
activity, thus classified as non- provitamin A.[14]  
1.2.2. Color 
Structure of carotenoids is responsible for their pale yellow to deep red 
color. The conjugated double bond system allows free movement of 
electrons across the hydrocarbon backbone of the molecule. As the number 
of conjugated double bonds increases, electron movement through the 
molecule requires less energy to occur. Which allows more absorbance of 
light from the low frequency end of the visible spectrum, thus compounds 
acquire an increasingly red color. [14] 
1.2.3. Solubility 
Carotenoids belong to the fat soluble vitamins category which include also 
vitamins A, D, E and K these groups of compounds are characterized by 
limited water solubility, and hence bioavailability. This attribute is due to the 
presence of long unsaturated aliphatic chains as in some fatty acids. Thus, 
the biological absorption of carotenoids and the other fat soluble vitamins 
depend completely on the presence of fats and bile salts. [14] 
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Functional compounds like carotenoids are usually used as active ingredients 
in different food stuff. Yet, the hydrophobic property of these ingredients 
has made their use in different food formulations very difficult. Thus, food 
technologists started to explore different opportunities through 
nanotechnology to enhance the hydrophilic character of such functional 
ingredients and to improve bioavailability. [15] 
 
1.2.4. β- carotene 
β-carotene has been identified as the most common carotenoid in vegetables 
and fruits, and due to its outstanding bright coloring effect, it is introduced to 
many food, cosmetic and personal care products, in where also the proposed 
health protective benefit of β-carotene is taken into account. β-carotene is 
found naturally and at very high amounts in apricot, carrot, dark green leafy 
vegetables, squash and colored peppers.[16]  
1.2.5. Biosynthesis 
The biosynthesis of carotenoids in plants is done through the following 
enzymatic pathway: 
 
 In each enzymatic step starting from phytoene till lycopene, only one 
double bond is added to the molecule, resulting in lycopene, which is a 13 
double bonds symmetrical molecule. After Lycopene synthesis, cyclization 
enzyme starts to cyclize the end groups, which results in molecules having 
one beta ring (γ –carotene) another one having two beta rings (β-carotene). 
Adding oxygen to the molecule results in the formation of xanthophylls [16] 
1.2.6. Pharmacological effects 
Moreover, Beta-carotene exhibits pro-vitamin A activity and it is also 
considered a potent biological antioxidant, [16] as it has a very high ability 
to quench singlet molecular oxygen and free radicals. This effect is achieved 
by preventing radical chain reaction of lipid peroxidation that takes place in 
bio-membranes, and scavenging lipid peroxyl radicals to produce stable non-
radical products.[14]  
Phytoene --˃phytofluene --˃ ζ-carotene --˃ neurosporene --˃ lycopene --˃ γ-carotene and β-carotene 
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Figure 1-4. Beta-carotene with two cyclohexene type end groups.[17] 
 
The powerful antioxidant property of beta-carotene has led to its ability to 
reduce the risk of different diseases that are related to cells damage. Many 
Studies have proven that high consumption of vegetables and fruits 
containing β- carotene will reduce the risk of developing diseases such as 
cancer, cardiovascular diseases, photosensitivity and aged-linked disorders, 
however, recent studies, had referred to a negative relationship between β- 
carotene consumption and lung cancer and cardiovascular disease in 
smokers.[18] 
1.3. Micronutrients (Trace minerals) 
Trace minerals or micronutrients are group of ions (like iron, zinc, 
manganese, copper and selenium) that the body needs in a very small 
amount. The averages of recommended dietary allowances (RDA) for trace 
minerals are between 0.2 - 15 milligrams per day.  
1.3.1. Zinc  
Zinc is a trace mineral that is needed for the growth and development of 
nervous, immune and reproductive systems. Indeed, it is essential for many 
vital processes in the body like protein folding, nucleic acid synthesis, gene 
expression regulation, and catalysis of more than 100 enzymes. Thus, it is 
involved in cell division activity and ideal hormone level maintenance.  
Zinc also is classified as a potent antioxidant that can scavenge free radicals 
and active oxygen species that affects cell integrity and induces tissue 
inflammation. However, many studies had reported that around 40% of the 
whole population are estimated to be deficient in zinc. And this deficiency is 
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due to the inadequate consumption of zinc rich food and the low 
bioavailability. The RDA of zinc is around 2 to 3 milligrams per day for 
adults.   Insufficient intake of zinc is linked to incidence diarrhea, malaria in 
children, impaired cognitive function, low immunity, infertility, slow wound 
healing, giving birth to underweight infants and low respiratory tract 
infections. 
Zinc metal ions have a role in β-carotene (pro-vitamin A) metabolism, 
including its absorption, transport, and utilization [19]. It is therefore 
recommended to combine zinc ions with β-carotene supplementation.  
In conclusion, increasing the dietary intake of beta-carotene and zinc 
through food formulation enriched with unique nanoparticles systems is of 
great benefit in improving the micronutrient state in malnourished adults and 
children specifically in developing countries.  
1.4. Statement of purpose: 
The scope of this work is to investigate the potential of whey protein isolate 
nanoparticles for storing carotenoids (i.e. β-carotene) and trace minerals (i.e. 
zinc), as well as their release, this entails: 
 Preparation of β-carotene and zinc loaded whey protein nanoparticles. 
 Characterizing the complex by evaluating the morphology, particle 
size, stability and loading efficiency of the whey protein 
nanoparticles. 
 Studying the release behavior of the beta carotene and zinc from the 
encapsulated whey protein nanoparticles. 
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Chapter 2. Literature review: 
 
2.1. Methods for whey protein isolate nanoparticles preparation:  
 
Protein nanoparticles are generally used for encapsulation and delivery of 
pharmacologically active compounds as they can deliver the active 
compounds with high ratio of absorption to a particular tissue of the body. 
Thus, and due to their unique physicochemical characteristics, whey protein 
nanoparticles could be a good candidate for novel food as well as nonfood 
applications. Different preparation method for whey protein nanoparticles 
were proposed by different research groups. 
Preparation of whey protein isolate nanoparticles through pH cycle was first 
carried out by Hélèn et al where they formulated controlled size 
nanoparticles by cross-linking of denatured whey protein strands at low 
temperature and controlled pH cycle. Heating whey protein at pH 7 and low 
ionic strength produced soluble polymers, which were acidified then 
neutralized again to produce nanoparticles. The particle sizes of the 
produced nanoparticles ranged from 100 to 300 d.nm depending on the 
aggregation pH (either 5, 5.5 or 6.0), the ageing time at the aggregation pH 
(0–75 h) and calcium concentration (0, 2.5, 5 mM). It was confirmed that 
increasing the calcium concentration increased the turbidity and particle size 
but it decreased the voluminosity of the nanoparticle dispersion. Introducing 
calcium to the formulation increased the particle compactness with an 
impact on the delivery and protection abilities of the nanoparticles. On the 
other hand, the diameter size increased by increasing the ageing time of the 
formulation, due to the formation of disulfide bonds which were responsible 
for particle intra -cross links. Finally, the authors suggested using the formed 
nanoparticles for the encapsulation of aroma and pharmacologically active 
compounds to benefit from their outstanding abilities. [20] 
 
In 2012, another method of whey protein isolate nanoparticles preparation 
was proposed by Gülseren et al. This entailed diluting whey protein solution 
by ethanol at alkaline pH, then immediately diluting in buffers (either at pH 
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7 or 3). The size of the formed nanoparticles ranged from 10-100nm. 
However the particle size could be modified by a combination of 
homogenization and heating. There was no substantial difference in the 
interfacial properties between the  nanoparticles prepared by the desolvation 
method and the corresponding original protein solution which may suggest 
the use of whey protein nanoparticles to enhance emulsions` stability. [6] 
A heat-stable whey protein nanoparticles with very low turbidity level could 
be formed by following the same method proposed by Zhang et al. The 
method involved incorporating thermally pretreated whey protein molecules 
in nano-micelles of water in an oil emulsion to produce whey protein 
nanoparticles with less than 100nm particle size. The pH of the formula 
during the preparation had a significant effect on the stability of the final 
formulation, as nanoparticles produced from neutral protein solution showed 
higher thermal stability than those produced from acidic solution. Indeed, 
the main objective of Zhang`s study was to retard the heat induced gelation 
property of the very tiny whey protein particles (i.e. ˂ 100 nm) to allow its 
use in clear beverages.  [21] 
Hebrard et al. used whey protein (WP) isolate and alginate (ALG) for the 
encapsulation of a valuable type of Saccharomyces boulardii yeasts . The 
formulated microparticles were able to protect the yeast and control its 
delivery throughout the gastrointestinal tract. The method used for particles 
preparation was the extrusion/ cold gelation method by means of  an 
“encapsulator” device which uses a vibrating nozzle to induce laminar jet 
break up. The results showed that a formula composed of 62 % whey protein 
to 38 % alginate was able to protect up to 40% of the yeast cells compared 
with only 10% survival rate for free yeast cells in simulated gastric intestinal 
fluid, even in the presence of digestive enzymes like pepsin and pancreatin.  
Coating the WP/ALG microparticles with alginate led to higher survival rate 
of yeast cells, which could be attributed to the shrinkage behavior of ALG`s 
matrix in gastro intestinal fluids. This would limit the passage of digestive 
enzymes through its network leading to a higher survival rate of probiotics. 
The release of yeast cells from the microparticles was shown to occur due to 
alginate swelling and whey protein hydrolysis in intestinal fluid. Probiotics 
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loaded microparticles can be used for many applications in food as well as 
pharmaceutical industry for better protection of the laded organisms.[22] 
 
2.2. Use of whey protein for encapsulation and drug delivery application: 
 
In 2007, Gunasekaran et al. studied the use of whey proteins as hydrogels 
and/or nanoparticles systems for the encapsulation and controlled release of 
pharmacologically active compounds. Indeed, individual whey proteins 
show high swelling sensitivity towards pHs that are higher than their 
isoelectric point. Caffeine was used as model drug to examine the controlled 
release ability of whey protein hydrogels. However the results confirmed 
that the release of caffeine from hydrogels was slower at pHs lower than the 
isoelectric pH (the pH at which the net charge of protein equals zero). 
Sodium alginate coatings can also be used to further control the sustained 
release behavior of whey protein hydrogels. Gunasekaran et al also 
formulated beta-lactoglobulin (BLG) nanoparticles by the desolvation method 
and the average size of the resulted nanoparticles was less than 100nm. 
Preheating the BLG solution to 60°C before the nanoparticle formation 
would decrease the average size and improve the uniformity of the yielded 
nanoparticles. The stability of the nanoparticles suspension at different pHs 
was investigated and the results revealed that their stability at neutral pH 
was higher than acidic pH even in the presence of proteolytic enzymes. This 
could be explained by the highly dense structure of the nanoparticles. [12] 
In 2011, Giroux et al succeeded in encapsulating a hydrophobic aroma (i.e. 
ethyl hexanoate) in whey protein nanoparticles through pH cycling method. 
The size of the produced nanoparticles was less than 300 nm in diameter. 
Moreover, nano-particulation of lipophilic aroma resulted in better retention 
of aroma and less mass transfer at the surface of the matrix. The efficiency 
of encapsulation was tested by comparing the release behavior of aroma 
from nanoparticles and from native whey protein, however the results 
showed that the release of aroma from nanoparticles was significantly lower 
than that from native whey protein which confirms the encapsulation 
efficiency of nanoparticles. The study had confirmed also that for better 
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entrapment of aroma in the cross linking network it should be first, added 
before pH cycling, second, produced at pH 5.0 and 5.5, and third, without 
calcium addition, to make sure that the structure of the produced 
nanoparticles is more porous and less compact and hence better entrapment 
capacity.  In conclusion, nanoparticulation of hydrophobic aromas or flavors 
in whey protein could be used as a method to control their release in low or 
non-fat foodstuffs.[23] 
In the same respect, in 2014, Abbasi et al studied the loading of Vitamin D3 
in whey protein isolate (WPI) nanoparticles prepared by pH cycling at 
different calcium concentration. The stability of the formula was tested in 
the presence of oxygen for 7 days. Results suggested that the whey protein 
nanopartricles had the ability to retain more vitamin D3 than control samples 
of native whey protein isolate and of denatured whey protein. The authors 
confirmed  that adding the active compounds before pH cycling led to better 
entrapment. Adding calcium during nanoparticle preparation resulted in a 
more dense structure which provided further protection for the entrapped 
vitamin D3. The kinetics of vitamin D3 release during storage time followed 
a second order model.  Results showed that these nanoparticles may be used 
as enriching agent in different beverages and foodstuffs.[24]  
In 2012, Gülseren et al, succeeded in incorporating the daily required 
amount of zinc for adults in whey protein isolate (WPI) nanoparticles by 
applying the ethanol desolvation method. The volume of ethanol added was 
0–3 times the volume of protein dispersion and the desolvation took place at 
pH 9. However, directly after desolvation, the desolvated solutions were 
dispersed in acidic water (pH 3). The size of produced nanoparticles was 
controlled by the amount of ZnCl used and the ethanol to water ratio. It was 
found to increase by increasing these factors. The encapsulation capacity of 
whey protein nanoparticles for zinc was studied and the results showed that 
the amount of zinc retained was high and remained stable for 30 days at 
22°C.  In this respect, whey protein nanoparticles could act as a reservoir for 
sensitive hydrophilic materials, which would allow their addition to different 
beverages and food products. [25] 
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Another research group embedded ZnO nanoparticles in a whey protein 
isolate matrix to provide protection for Zn mineral in gastric pH and 
improve its bioavailability. Transmission electron microscopy and X-Ray 
diffraction results confirmed the successful synthesis of ZnO-WPI nano-
scaled composite structure of 300 nm average size and uniform mono-
dispersal embedment of ZnO in the structure. [26] 
 
2.3. Beta carotene in nano-forms  
 
β-carotene, which is a lipophilic carotenoid is of great interest mainly 
because it is one of the most effective precursors for vitamin A, and also 
because it has other potential health effects, such as being a cancer 
prevention agent, life extender, ulcer and heart attack inhibitor. However, its 
utilization is limited due to its poor water-solubility and chemical instability. 
Thus, β-carotene has to be dissolved in oils or other appropriate solvents 
before being utilized in foods. Moreover, β-Carotene is extremely 
susceptible to chemical degradation during food processing and storage. 
Hence, improving the thermal and chemical stability as well as solubility 
profile is an important challenge for β-carotene utilization in different food 
and pharmaceutical applications. [27] 
Guanghua et al. used human H chain ferritin (rHuHF) which is naturally 
present with a shell-like structure and reversible dissociation and reassembly 
properties at different pHs to encapsulate β-carotene and hence enhance its 
thermal stability and water solubility. High-performance liquid 
chromatography (HPLC), transmission electron microscope (TEM) and 
UV/Vis spectroscopy showed that β-carotene molecules were successfully 
encapsulated within protein cages and each cage contains 12.4 molecules of 
β-carotene. Moreover the water solubility of β-carotene encapsulated within 
protein cages was higher when compared with freely oil soluble β-carotene 
molecules. Additionally, its thermal stability was noticeably improved. This 
would allow the utilization of β-carotene in food industry. [27] 
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In the same respect, Zhong et al. tried to encapsulate β-carotene in different 
food proteins like whey protein isolate, sodium caseinate and soybean 
protein isolate. The technique used for their preparation was the 
homogenization-evaporation technique in which β-carotene solution was 
added to the protein solutions and homogenized at different speeds before 
the evaporation step taking place to remove the extra solvent. The results of 
the chemical antioxidant assays showed that the free radical scavenging 
activity and the reducing power of encapsulated β-carotene was higher than 
the free form when tested on Caco-2 cells (i.e. human intestinal cell line). 
Fourier transfer infrared (FT-IR) as well as X-ray diffraction (XRD) findings 
showed that β-carotene became amorphous after encapsulation in food 
proteins. The in-vitro release studies indicated that β-carotene that was 
encapsulated in whey protein isolate had the best delivery profile and it was 
able to survive pepsin in the gastric medium and release the β-carotene in 
the intestine under the effect of trypsin enzyme. [28]  
Yassin et al. encapsulated β-carotene in polysorbate-80-coated poly(d,l-
lactide-co-glycolide) nanoparticles to treat epileptic convulsion. The 
prepared nanoparticles had the ability to target the brain and exhibit high 
antioxidant activity to treat epileptic convulsions. Solvent evaporation was 
used to prepare the nanoparticles. The dose in the formula that was shown to 
be effective in treating epileptic convulsions is 2 mg/kg. However the same 
“unformulated” amount of β-carotene dose exerted no effect in vivo. The 
findings proved that β-carotene encapsulated in Tween-80 polymer can be 
used as a novel anti-convulsant drug with very high stability, bioavailability 
as well as drug selectivity even at very low doses.[29] 
In 2014, Sheng et al. tried to prepare β-carotene molecules as nanoparticles 
by anti-solvent precipitation with the assistance of ultra-sounds. The workers 
also studied the effect of different process parameters on the formulation. 
For example, at an efficient concentration of 5–15 mg/ml, the nanoparticles 
precipitating under 1 minute ultrasound had smaller size (112–141 nm) than 
the other nanoparticles that were processed without ultrasonication(144–365 
nm). Moreover, without ultrasound, the order of anti-solvent (i.e. water) 
addition was shown to have a significant impact on the particle size: adding 
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water to the active solution led to larger particles than adding the active 
solution to the water. Furthermore, the ratio of active solution to anti-solvent 
volume affected the particle size considerably, as decreasing the active 
solution to anti-solvent from 1:1 to 1:4 without ultrasound decreased the 
particle size from 432 to 223 nm. Finally the produced β-carotene 
nanoparticles precipitated under ultrasound exhibiting higher dissolution 
than free β-carotene molecules and nanoparticles precipitated without 
ultrasound. [30] 
Martín et al. used supercritical anti-solvent precipitation technique from an 
oil-in-water emulsion to prepare a β-carotene nano-suspension with a 
controlled particle size. The technique was composed of a two-step process 
strategy. The first one involved a short contact between CO2 and the 
emulsion till the saturation of the disperse phase. This was carried out in 
order to achieve the precipitation by the effect of anti-solvent. On the other 
hand, the second step involved an extended contact between the emulsion 
and CO2 in order to eliminate the organic solvent residual. The produced 
particle size was less than 400 nm in suspension. Martin et al used a 
modified edible starch surfactant because it could be used as a coating 
material for the final dried nanoparticles that were produced by 
lyophilization technique. However, the results showed that β-carotene got 
encapsulated in the micelles formed by the surfactant with a final 
concentration of organic solvent as low as 1 ppm.  [31] 
Similarly, the preparation of β-carotene nanosuspension using green, solvent 
free method was studied in 2012 by Tien. The partially water-soluble 
compound “Triacetin” was used in the nanoemulsion as a dispersed phase. 
However, the effect of water concentration, surfactant and homogenization 
time on the stability and particle size was also investigated. The Particle size 
and zeta potential (that measures the electro-kinetic potential of nano-
suspensions) results showed that most stable β-carotene nanosuspension was 
obtained at 98% water concentration and 5% lecithin “based on emulsion 
mass” for 4 minutes emulsification. Also, the specified nanosuspension  
showed high physico-chmical stability.[32] 
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In 2006, Anantachoke et al tried to formulate β-carotene monodispersed 
nanoparticles using spinning disk processing (SDP), (where a very high 
centrifugal force is created under the effect of the spinning desk, and this 
force in the presence of high voltage will cause particle repulsion to yiels 
nanoparticles) under the electric shown in Figure 2-1. This creates very thin 
(1 to 200 µm) fluid layers on a rapidly spinning surface (10 to 3000 rpm), 
within which nano particulation takes place. Indeed, some surfactants were 
used to stabilize the nanoparticles at very low particle size. Dynamic light 
scattering results showed that the size of the particles varied with surfactant 
variation. However transmission electron microscopy (TEM) confirmed the 
spheroidal shape of the produced β-carotene nanoparticles. In brief, SDP 
technique can be used to produce organic nanoparticles that can be used for 
drug delivery systems and food fortification applications. [33] 
 
 
Figure 2-1. Schematic diagram for the SDP and the nucleation process that 
occurs on the disk.[33] 
 
In 2012, Lacatusu et al. studied the use of squalene and grape seed oils as 
natural antioxidant oils to prepare nanostructured lipid carriers (NLCs) with 
the aim of protecting and stabilizing the sensitive β-carotene molecule. 
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Practically this was achieved by preparing several oil-in-water nano-
emulsions stabilized by a mixture of surfactants at different high shear 
homogenization processes. The in-vitro results of β-carotene loaded NLC 
showed that the antioxidant activity of β-carotene after loading was 
enhanced and this was confirmed by the free oxygen quenching ability.  
Additionally, the prepared β-carotene-NLCs exhibited excellent physical 
stability with almost all zeta potential values. [34] 
2.4. Zinc micronutrient in nanoparticles  
Zinc oxide and other oxide nanomaterials were shown to have cytotoxic as 
well as anti-bacterial activity, thus, a simple way for ZnO nanoparticle 
synthesis from ZnCl2 was proposed by Renugadevi et al.  The size and 
composition of the produced nanoparticles were analyzed using Scanning 
Electron Microscopy (SEM) and Energy Dispersive Spectroscopy (EDX). 
The antibacterial effect of ZnO was studied by the disc diffusion method 
against Bacillus subtilis, Bacillus cereus, Staphylococcus aureus, Salmonella 
typhi, and Vibrio cholera. Moreover, the cytotoxic activity of the 
nanoparticles was examined against Vero cell line. In conclusion, the results 
confirmed the antibacterial activity of ZnO nanoparticles against all the 
previously mentioned strains of bacteria. However the cytotoxicity of ZnO 
nanoparticles was shown to be less than ZnCl2 on Vero cell line.[35] 
Raspopov et al. examined the effect of ZnO nano-particulation on the 
intestinal uptake and bioavailability of zinc on rats. The results showed that 
serum level of zinc was higher in rats treated with ZnO nanoparticles with 
respect to control samples (rats treated with normal Zn supplement). Also, it 
was confirmed that ZnO nanoparticles aided in the intestinal uptake of some 
macromolecules like egg albumin and other immune factors. [36]   
2.5. Combining β-carotene with zinc for better pharmacological activity: 
Combining zinc with β-carotene, as a pro-vitamin A molecule, enhances the 
therapeutic effects of the latter. In this respect, Dijkhuizen et al. examined 
the effect of iron and folic acid plus β-carotene or zinc or both during 
pregnancy to improve the micronutrient level of mothers and infants post-
delivery. The results showed that vitamin A level was only improved when 
β-carotene was combined with zinc, as this aided in the conversion of more 
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β carotene molecules to vitamin A. However, the improvement of vitamin A 
was reflected on its increased content in breast milk and this consequently 
increased the vitamin A status of the infants. Indeed, adding zinc to β-
carotene proved to be an efficient and cost-effective method to improve the 
healthiness of both lactating mothers and infants.[37] 
In order to maximize the biological effect of β-carotene, Wieringa et al. 
tested the effect of zinc combined with β-carotene to treat micronutrient 
deficiencies in pregnant women. The findings revealed that maternal zinc 
and β-carotene supplementation enhanced the immunity functions in 
newborns, and such effective formula might be used in rural areas to 
decrease morbidity rate in infants in these areas.   [38]  
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Chapter 3: Materials and methods 
3.1. Materials 
All materials were obtained and used without any extra purification. The 
following was used: 
 Hexane (HPLC grade), Potassium bromide, Sodium phosphate 
monobasic di-hydrate (99%), Hydrochloric acid 37%, 
Dichloromethane (≥95%) and Beta carotene powder, Synthetic (≥ 
93%) from Sigma Aldrich, UK.  
 Bipro Whey protein isolate 92.6% (w/w) from Davisco Foods 
International Inc., Eden Prairie, USA.  
 Calcium chloride, granulated, extra pure and Pepsin 1:3000 from 
Scharlau S.L., Spain.  
 Ethanol absolute anhydrous from Carlo Erba Reagents, France.  
 Sodium azide (≥ 98%) from Acros Organics, Belgium.  
 Sodium hydroxide (≥ 98%) from Bio.chem, Egypt.  
 Sodium phosphate dibasic obtained from Fine Chem, Egypt.  
 Trypsin enzyme 2656.7 u/mg obtained from FAIZYME laboratories, 
Egypt. 
 Zinc chloride (≥97%) from Laboratory Rasayan, India. HPLC water 
from Milli Q, Germany. 
 PVDF filter of 0.45µm from Sigma Aldrich, UK.  
 
3.2. Equipment 
 pH meter (Accumet AR10) to adjust the pH of the formulation, 
centrifuge (Centrific) to separate the protein particles from the 
supernatant and Heratherm Oven, all obtained from Fischer scientific, 
UK.  
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 Sonicator (150HT) to facilitate the dissociation of large whey protein 
nanoparticle aggregates. And Stirrer (VWR) from ETL testing 
laboratories, INC., USA.  
 Vortex (V1 plus) for sample mixing from Boeco, Germany.  
 Recipocal shaking bath (Model 25) from Precision scientific 
Instruments, Inc., USA.  
 Zeta sizer (Image 3-1) (Nano-ZS90) to determine particle size, from 
Malvern Instruments, UK.  
 
 Field emission scanning electron microscope (FESEM) to study the 
surface morphology of the nanoparticles (Supra 55) operated at 23 kV 
from Leo Zeiss, Germany  
 
 Fourier transform infrared spectrometer (FTIR) (Nicolet 380) to 
determine the structure of the particles as well as the original 
materials. Obtained from Thermo Fischer scientific Inc., UK. 
 
• High Performance Liquid Chromatography (HPLC) (DIONEX 
Ultimate 3000 Series) equipped with Ultimate 3000 pump and Photo 
Diode Array detector to determine β-carotene concentration in the 
nanoparticle preparation as well as the control sample. Peaks were 
separated on a BDS HYPERSIL C18 column using a mobile phase 
system composed of acetonitrile and dichloromethane (3:1) (v/v). The 
HPLC was operated in isocratic mode at flow rate of 1.5 ml/min. The 
absorption of β-carotene was detected at 450 nm, as this was found to 
be the wavelength of maximum absorption after scanning it in the 
visible range (450 nm-600). 20 µl sample was injected automatically 
using Ultimate 3000 autosampler and Chromeleon was used for peak 
integration and calculation. HPLC obtained from Thermo Fischer 
scientific Inc. UK.  
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 Ultraviolet Visible (UV-Vis) spectrometer (Spectronic 20 D+), using 
Tungesten lamp, to determine the concentration of β-carotene 
released, from Thermo Electron Corporation, UK. 
 Atomic absorption (200 series) operating with Zinc lamp at λ 213.9 
nm to determine the concentration of zinc ions incorporated in 
nanoparticles, from Agilent Technologies, USA. 
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3.3. Sample preparation 
3.3.1. Preparation of whey protein soluble polymers 
Whey protein isolate (WPI) dispersion of 8% (w/v) was prepared using 
deionized water and adjusted with 1N NaOH to pH 7.0. In order to prevent 
microbial growth, sodium azide was added at 0.02% (w/v). The dispersion 
was kept refrigerated at 4°C overnight for complete hydration, then it was 
warmed to room temperature and degassed for 20 minutes under vacuum 
(560 mm Hg). The dispersion was then warmed up in a water bath to 80°C at 
a heating rate of 8°C/min and kept for 15 minutes at this temperature. The 
preparation was then cooled to room temperature on an ice bath, and a 
dilution of 2% (v/v) from the above protein concentrate in deionized water 
was prepared.  
 
3.3.2. Preparation of β carotene and zinc loaded nanoparticles 
The nanoparticles were prepared by the pH-cycling method previously 
described by Giroux et al. [20] as it is the method described for 
incorporation of hydrophobic moieties in whey protein isolate nanoparticles, 
but after introducing some modifications. A volume of 4 ml of 0.25 mg/ml β 
carotene in absolute ethanol was added per 250 ml WPI preparation. The 
mixture was then acidified under stirring using 0.1N HCl to an aggregation 
pH of 6.0. To this mixture, 1 ml of 62.5 mg/ml CaCl2 solution and 1 ml of 
7.5 mg/ml ZnCl2 solution were added to reach final concentration of 2.25 
mM and 0.25 mM respectively in the final mixture. These concentrations 
were determined after trying different concentration`s ratios and found that 
the previously stated one is the ideal one in terms of turbidity of the 
produced preparation and uniformity of particle size. 
The preparation was left at 4°C in the fridge for an aggregation period of 22 
h to allow the di-sulphide bonds to form. The dispersion was then brought to 
pH 7 using 1N NaOH at room temperature to disrupt the non-covalent bonds 
and restore the electrostatic repulsions of aggregates. For further dissociation 
of nanoparticles aggregates; the dispersion was sonicated for 10 minutes at 
room temperature.  
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Part of the formula was kept in the liquid form for particle size, HPLC and 
atomic absorption analysis, while the rest of the formula (200 ml) was dried 
through the following procedure.  
3.3.3. Sample drying 
200 ml from the β-carotene and zinc loaded nanoparticle preparation was 
filtered through 3µm pore size filter paper. The precipitate was then washed 
using 20 ml hexane then the precipitate was collected in a porcelain dish, 
and allowed to dry under vacuum overnight. The large particles in the dried 
precipitate was then ground using a mortar and pestle. The particles were 
used then for FTIR analysis and in-vitro release study using UV 
spectrometer. 
 
3.3.4. Preparation of blank sample  
A blank sample of whey protein nanoparticles was prepared by the same 
method but without the addition of β-carotene and zinc. Where 250 ml WPI 
was acidified under stirring using 0.1N HCl to an aggregation pH of 6.0. To 
this mixture, 1.1 ml of 62.5 mg/ml CaCl2 solution was added to reach final 
concentration of 2.5 mM in the final mixture. The preparation was left at 
4°C in the fridge for an aggregation period of 22 h. the dispersion was then 
brought to pH 7 using 1N NaOH at room temperature and then sonicated for 
10 minutes at room temperature.  
 
3.3.5. Preparation of control sample 
A control sample of β-carotene was prepared at the same time by adding 
same amount of β-carotene (.005g) in 4 ml ethanol and added drop wise per 
250 ml deionized water under stirring at room temperature.  
All samples (control sample and β-carotene and zinc loaded nanoparticles) 
were stored in closed volumetric flasks, covered with aluminum foil to be 
protected from light at stored room temperature.    
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3.4. Characterization of nanoparticles 
3.4.1. Encapsulation efficiency: 
The encapsulation efficiency for β-carotene in whey protein isolate 
nanoparticles was determined by measuring the amount of β-carotene lost in 
the filtrate after filtering the 200 ml loaded nanoparticle preparation; where 5 
ml hexane were used to extract β-carotene from 5 ml filtrate. Also, the 
amount of β-carotene in the 20 mls hexane used to wash loaded 
nanoparticles was determined using pre-constructed calibration curve on UV 
at 448 nm. (Appendix)  
𝐸𝑛𝑐𝑎𝑝𝑠𝑢𝑙𝑎𝑡𝑖𝑜𝑛 𝑒𝑓𝑓𝑖𝑐𝑖𝑒𝑛𝑐𝑦 
= 𝑤𝑒𝑖𝑔ℎ𝑡 𝑜𝑓 𝑡ℎ𝑒 𝑙𝑜𝑎𝑑𝑒𝑑 𝑑𝑟𝑢𝑔
/ 𝑡ℎ𝑒 𝑤𝑒𝑖𝑔ℎ𝑡 𝑜𝑓 𝑡ℎ𝑒 𝑖𝑛𝑝𝑢𝑡 𝑑𝑟𝑢𝑔 ∗ 100   
 
3.4.2. Particle size analysis 
1 ml of deionized water added to 1 ml of the final preparation (either blank 
whey protein nanoparticles or β-carotene and zinc loaded nanoparticles) and 
filtered through a 0.45 µm PVDF syringe then used for particle size analysis 
by dynamic light scattering at room temperature using 90 degree scattering 
optics  
 
3.4.3. Scanning electron microscope: 
One ml of nanoparticle formulation was filtered through a 0.45µm 
membrane disc filter, the filtrate was then centrifuged at very low speed (i.e. 
100 rpm) for 10 minutes, as the protein nanoparticles are so fragile that even 
very low shearing force may result in particle disruption. Then the 
supernatant was disregarded to remove residual salts and the precipitate was 
re-dispersed again in 1ml fresh de-ionized water. The dispersion was then 
allowed to dry on aluminum sheet under nitrogen gas at room temperature 
and used as it is without sputtering for obtaining Scanning Electron 
Microscope images.  
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3.4.4 FT-IR (Fourier Transform Infrared Spectrophotometer): 
FTIR spectra were obtained for untreated whey protein powder, pure β-
carotene powder and β-carotene and zinc loaded whey protein nanoparticles 
using the KBr (Potassium Bromide) pellet method. About 0.1 mg of sample 
was mixed with about 1 g of spectroscopic grade KBr and subjected to 1400 
KPa hydraulic pressure to produce the pellets which were characterized 
using FTIR instrument.  
 
3.5. Stability study for β-carotene loaded in nanoparticles for HPLC analysis  
The total amount of the β-carotene retained in whey protein nanoparticles 
was determined according to the method proposed by Abbasi et al. but with 
some modifications. [24] It is a liquid extraction method, where 1 ml of 
HPLC grade water and 1 ml of absolute ethanol were mixed with 1 ml of the 
β-carotene and zinc loaded whey protein nanoparticles after 1, 2, 5, and 7 
days from the preparation date, to extract the β-carotene remained in the 
whey protein nanoparticles at these intervals. The mixture was vortexed for 
1 minute at room temperature. 1 ml of hexane (immiscible with water) was 
then used to extract β-carotene from the water ethanol mixture and vortexed 
again for 1 minute at room temperature. This was followed by centrifugation 
at 400 rpm for 2 min and then the organic upper solution was transferred to a 
falcon tube and allowed to evaporate under nitrogen gas. Subsequently, 1 ml 
of mixture of acetonitrile and dichloromethane (3:1) (v/v) was added to 
dissolve the β-carotene residues remained after evaporation and used for 
HPLC analysis. The concentrations of β-carotene in whey protein 
nanoparticles were measured against control sample also stored for  1, 2, 5 
and 7 days.  
3.6. In vitro release of β-carotene from whey protein nanoparticles: 
In vitro release is performed in simulated intestinal/gastric fluid at 37°C 
under acidic and neutral conditions after drying the β-carotene and zinc 
loaded whey protein nanoparticles.  
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3.6.1. Preparation of simulated intestinal fluid 
0.1 M phosphate buffer solution was prepared by dissolving 7.0g of 
NaH2PO4 and 21.8g Na2HPO4 in deionized water to make a total volume of 
2 liters. The pH of the final solution was adjusted to 7.4 using 2N NaOH, 
and stored at 4°C. Finally, 2.0g of trypsin (intestinal enzyme) and 2.0g of 
sodium dodecyl sulfate, SDS, were added to the solution just before the 
analysis. 
3.6.2. Preparation of simulated gastric fluid 
A 2 liters of 0.1 M Phosphate buffer solution was adjusted to pH 1.6 with 
2N HCl and stored at 4̊ C. Then 2.0g of pepsin enzyme was dissolved in the 
above buffer before the analysis at room temperature.  
 
3.6.3. In vitro β-carotene release: 
Both simulated fluids were incubated at 37°C in water bath for 1 hour before 
mixing with particles to be analyzed. The pre-weighed dried particles were 
divided into 15 portions and each portion was added to 20 ml simulated fluid 
in closed container. Each container was incubated at 37 ̊C in water bath with 
shaker at 200 shakes per minute at different times as specified in table 3-1 
below;  
Table 3-1. Dried particles in simulated fluids at different incubation 
periods. 
Medium 
Incubation time 
(min/hr) 
Gastric simulated fluid  
5 min 
10 min 
15 min 
30 min 
1 hr 
2 hr 
Intestinal simulated fluid  
1 hr 
2 hr 
4 hr 
6 hr 
8 hr 
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12 hr 
16 hr 
20 hr 
24 hr 
 
The released β-carotene in gastric fluid was solvent extracted with 20 ml 
Dichloromethane (DCM) and shaken for 2 minutes at room temperature then 
the lower layer was separated using a separating funnel. The absorbance was 
measured and the concentrations was determined using pre-constructed 
calibration curve at 460 nm.  
In the case of intestinal fluid, the β-carotene released in the solution was 
measured directly, due to the presence of the emulsifier (SDS) which aid in 
solubilizing the released β-carotene molecules. The absorbance was 
measured at 407 nm and the concentration wad determined using pre-
constructed calibration curve on UV (Appendix).   
 
3.6. Zn+2 determination by atomic absorption; 
Atomic absorption techniques was used to measure the amount of zinc that 
was successfully incorporated in β-carotene and zinc loaded whey protein 
nanoparticles and the amount that remained un-incorporated in the solution. 
In this respect, 1 ml of original β-carotene and zinc loaded whey protein 
nanoparticles diluted in 10 ml deionized water and vortexed for 1 min and 
left overnight at 70°C in closed vial to ensure complete degradation of 
protein nanoparticles, the solution was then used to determine total amount 
of zinc available in the solution (either free, adsorbed or incorporated in 
nanoparticles). 
 In another respect, 1 ml of β-carotene and zinc loaded whey protein 
nanoparticles preparation was filtered through 3 µm filter paper, the filtrate 
was then diluted with 10 ml deionized water and used for atomic absorption 
to determine the un-incorporated amount of zinc remained in the solution. 
However, the precipitate was then washed with 10 ml deionized water and 
used to measure the amount of zinc adsorbed on the nanoparticles without 
being incorporated in them.  
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However, all samples were used directly for Zn+2 concentration 
determination using calibration curve on atomic absorption 
spectrophotometer.  
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Chapter 4. Results and discussion 
This chapter offers interpretation and discussion of the characterization, 
stability and release profile results for the zinc and β carotene loaded whey 
protein nanoparticles.  These results were obtained through Zeta sizer, FTIR, 
SEM, HPLC, Atomic absorption and UV to quantify the amount of drug 
released in gastric and intestinal medium.  
4.1. Encapsulation efficiency: 
97% from the total amount of β-carotene added were successfully 
encapsulated in whey protein nanoparticles.  
4.2. Particle size analysis 
 
Table 4-1. summarizes the dynamic light scattering results of zinc and β-
carotene loaded whey protein nanoparticles compared to the blank particles. 
The polydispersity index (PdI) for both samples was determined to be in an 
acceptable range (0.0-0.7) implying that the particle size distribution values 
for both samples is not too high and the result quality according to these 
values is acceptable.  
However, there is a substantial difference between the particle sizes of whey 
protein nanoparticles and β-carotene loaded nanoparticles as shown in Table 
4-1.  The Z-average of whey protein nanoparticles was determined to be 
96.1 nm, while the Z-average of β-carotene loaded nanoparticles was shown 
to be 409.7 nm. These results were confirmed by the statistical data 
presented in Figure 4-1, where the average size of the whey protein 
nanoparticles is around 71 nm while that of the β-carotene and zinc loaded 
whey protein nanoparticles is 400 nm. Such differences between these 
average sizes strongly suggest that β-carotene and zinc were successfully 
incorporated in the whey protein nanoparticles.  It is thus not surprising that 
all the average sizes (Z-average, particle size and peak size distribution by 
volume) results of this formula were significantly larger than those of the 
blank samples (i.e. whey protein nanoparticles) although both formulations 
were prepared by the same method (pH cycle) and under the same 
conditions (aggregation pH 6 and ageing time 22 hr).  
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There is an important observation to note regarding Z-average in table 4-1 
and the average size distribution by volume in figure 4-1. The Z-average 
value of the blank whey protein nanoparticles was found to be 96.01 nm, 
however Figure 4-1 shows that the average size, based on volume, for these 
particles is around 71 nm. .  Presence of large aggregates may increase the 
overall Z-average value, however, this is confirmed by the presence of a 
very small peak at the right side of figure 4-1. Lovaley et al confirmed that , 
whey protein particles, by time, tend to aggregate and form large particles, 
due to hydrophobic and electrostatic interactions [39] Moreover, results 
obtained from DLS analysis are consistent with that obtained by Giroux et 
al, as Z-average of whey protein nanoparticles prepared at pH 6 and 22hr 
ageing time was 100 nm.[20] Same explanation could be applied to the 
results of formulated zinc and β- carotene loaded nanoparticles, as some 
particles may aggregate to shift the Z-average to higher value. This was 
confirmed by the presence of a very small peak at the right side of the graph 
4-1.  
Table 4-1. DLS results 
 
Parameter 
Whey protein 
nanoparticle 
Zn and β-carotene loaded 
nanoparticles 
PdI (poly dispersity 
index) 
0.346 0.269 
Z-average (d.nm) 96.19 409.7 
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Figure 4-1. Size distribution by volume for whey protein nanoparticles and β-carotene loaded 
whey protein nanoparticles. 
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4.3. SEM 
 
SEM images for whey protein nanoparticles as well as zinc and β-carotene 
loaded nanoparticles are shown in Figures 4-2, 4-3, 4-4 and 4-5, 4-6,4-7 
respectively. It is clear from the images shown in Figure 4-7 and 4-8 that 
whey protein nanoparticles have retained their spherical structure after zinc 
and β-carotene encapsulation.  Also both samples from a 2µm scale shows 
leaf like structure as in Figures 4-2 and 4-5. The major difference being the 
size of the particles, as the average size for zinc and β-carotene loaded whey 
protein nanoparticles from a 200 nm sclae(as in figure 4-7) is estimated to be 
larger than the blank whey protein nanoparticles (figure 4-3).  The whey 
protein nanoparticles in both samples tended to form large aggregates most 
likely due to the presence of charged species (i.e. Ca2+, Zn2+ and charged 
whey protein nanoparticles) and also due to hydrophobic interactions [39]. 
Same spherical shape of blank whey protein nanoparticles, were obtained by 
Gulseren et al, although the method of preparation was different, as they 
used ethanol desolvation method to prepare whey protein nanoparticles. [25] 
 
 
 
Figure 4-2. SEM image for whey protein nanoparticles (Blank) from 2 µm 
scale 
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Figure 4-3. SEM image of whey protein nanoparticles from 200 nm scale 
Figure 4-4. SEM images for whey protein nanoparticles from 200 nm scale 
(higher magnification) 
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Figure 4-8. SEM image for β-carotene and zinc loaded whey protein 
nanoparticles on a 200 nm scale 
Figure 4-6. SEM image for β-carotene and zinc loaded whey protein 
nanoparticles from 2µm scale 
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4.4. FT-IR: 
 
FT-IR characterization was conducted to determine whether the β-carotene 
had been successfully encapsulated in whey protein nanoparticles, as well as 
to determine the type of interactions that took place during the encapsulation 
process. The FTIR spectra of untreated whey protein, β-carotene as well as 
the zinc and β-carotene loaded nanoparticles are shown in the figure below 
(Fig. 4-8).  
Figure 4-7. SEM image for β-carotene and zinc loaded whey protein nanoparticles 
from a 300 nm magnification scale. 
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Figure 4-8. FTIR of pure β-carotene (Upper trace), zinc and β-carotene 
loaded whey protein nanoparticles (trace in the middle) and unloaded whey 
protein (lower trace). 
  
  
 
The upper trace represents the IR spectrum of β-carotene alone, where the 
peak of the C-H stretches vibrations in the alkyl group that is attached to the 
cyclohexene end group in β-carotene is seen at 2919 cm-1, however, the C-H 
aromatic appears on the left of C-H aliphatic at 3066 cm-1.  The very 
characteristic peak for the C=C stretches exist in the two terminal 
cyclohexene groups appears at 1625 cm-1, yet, the C-C stretches vibrations 
in cycle hexane ring is seen at 1457  cm-1 .[40] Another characteristic peak 
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of β-carotene molecule appears at 962 cm-1, which is characteristic for the C-
H of conjugated alkene. [28] 
The bottom trace of Figure 4-8 shows the IR spectrum of un-treated whey 
protein which consists mainly of α-lactalbumin and β-lactoglobulin along 
with minor proteins like bovine serum albumin and immunoglobulin G. The 
IR spectrum shows a very large peak at 3272 cm-1 which is very 
characteristic to the hydroxyl (OH) group that is present in many amino 
acids that build up the structure of α-lactalbumin and β-lactoglobulin, (the 
most abundant protein units in whey protein), these amino acids are 
Tyrosine, Threonine and Serine (Figure 4-9). [28]  
 
The very broad peak for the phenolic O-H stretch bond appears at 3450 cm-1, 
while the peak for the carboxylic O-H stretch vibration appears at 2960 cm-1, 
however there is an overlap between the phenolic OH and the amine (N-H) 
stretching peaks seen at 2434 cm-1, as both signals appear at almost the same 
wavenumber range. [40] Every amino acid contains one amine group but 
some like Tryptophan, Glutamine, Asparagine and Methionine have extra 
amine groups (Figure 4-10).  
  
Figure 4-9 Amino acids with (OH) polar groups [43] 
Tyrosine Threanine Serine 
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Figure  4-10. Amino acids with More than one amine group.[39] 
There is a significant peak at 1646 cm-1 corresponding to the amide C=O 
stretch vibration that links the amino acids together to form the peptide.  
Moreover, the C=C aromatic bending vibrations appeared at a characteristic 
wavenumber range from 1500-1700 cm-1. [41] 
The middle trace in Figure 4-8 represents the IR spectrum of zinc and β-
carotene loaded nanoparticles. The characteristic peaks for β-carotene and 
the whey protein were retained. Some shifts in the frequency of bands can be 
observed for the nanoparticle with the β-carotene. The O-H, N-H stretching 
peaks appeared with a very slight shift to lower frequencies. This may be 
due to a possible attraction between the amino acids and Ca+2 or Zn+2 ions 
added during the preparation of the drug loaded nanoparticles.  Calcium ions 
can interact with the proteins through sites such as OH and NH of the 
nanoparticles after protein denaturation.  This shift could also be attributed 
to possible hydrogen bonding occurring between some functional groups of 
the amino acid. Also the typical C=O of the whey protein as well as the C=C 
had appeared at a higher wavenumbers suggesting possible interactions with 
the metal ions. Thus it is concluded that adding β-carotene and Zinc 
Chloride to the whey protein suspension near the isoelectric point of the 
protein (which is at pH 6) had resulted in a very minimal changes in the IR 
Tryptophan Asparagine Glutamine
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spectra of both materials suggesting that the mechanism of encapsulation 
involved mainly hydrophobic or physical interactions. The addition of 
calcium chloride and zinc chloride at the same pH to neutralize the 
electrostatic charges of protein followed by letting the formula to age for 
~22 hr  (to allow the disulfide cross linking between protein strands to take 
place) also had resulted in formation of stable nanoparticles. 
 
4.5. HPLC analysis: 
 
HPLC analysis was carried out to examine the stabilizing and protecting 
effect of whey protein nanoparticles on β-carotene, which is known to be 
heat, light, and pH sensitive. Thus, HPLC testing for β-carotene loaded 
nanoparticles was conducted against control samples  
The HPLC results presented below (Figure 4-11) shows that at day 1 the 
amount of β-carotene retained in the nanoparticles was virtually the same as 
in the control sample.  The retention of β-carotene however was shown to be 
significantly higher in nanoparticles at 2, 5 and 7 day time points relative to 
the control.  
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 Figure 4-11.  Percentage of β-carotene retained at different storage 
intervals 
β-carotene is very susceptible to oxidation reactions under stressing 
conditions, like light, heat and reactive oxygen species. Figure 4-12 
illustrates the structures of β-carotene oxidation products resulting from 
reactions with reactive oxygen species (ROS). The process of β-carotene 
oxidation is an autocatalytic reaction, and this may explain the large drop 
(74% drop in case of test sample and 67% drop in case of loaded 
nanoparticles at day 7 ) in β-carotene concentration that took place in the 
control sample when compared to nanoparticle preparation, although both 
samples were kept in the dark at room temperature. The initiation of the 
autoxidation reaction was explained extensively by Boon et al. [42] where 
they proved that the initiation of the autoxidation happens when β-carotene 
goes through an isomerization step (which can occur easily even at 30 ̊C in a 
β-carotene solution) to form a bi-radical “twisted” molecule β-carotene bi-
radical (Figure 4-12).  The twisting of this molecule leads to an unpaired 
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5,6-Epoxide 
spin state, which makes it vulnerable to interactions with oxygen to form β-
carotene epoxides and endoperoxides.  
 
 
 
 
 
 
 
 
 
             O2 
 
 
 
 
 
 
 
 
 
 
 
  
Carbon-peroxyl triplet bi-radical 
  
β-carotene bi-radical 
 
      
  
β-carotene 
Endoperoxides 
46 
 
Figure 4-12. Structures of Auto oxidation by- products of β-carotene [14] 
On the other hand, β-carotene incorporated in whey protein nanoparticles 
showed higher stability profiles with respect to the control samples, as the 
incorporation process had limited the access of oxygen molecules to the 
entrapped β-carotene molecules leading to higher protection, hence, higher 
stability, and this was confirmed by the HPLC results shown in Figure 4-11.  
These finding were very close to that obtained by Abbasi et al , who studied 
the effect of vitamin D encapsulation in whey protein nanoparticles, Vitamin 
D3 is also susceptible to auto-oxidation reactions in the presence of light and 
air due to its conjugated triene structure (Figure 4-13). Abbasi et al 
confirmed that encapsulation of vitamin D3 in whey prtotein nanoparticles 
had increased its stability in the presence of air when compared with a 
control sample (Vitamin D3 in water-ethanol mixture) for 7 days, as the % of 
vitamin D3 retained after 7 days was almost double the amount retained in 
the control sample .  [24] 
 
 
 
4.6. In-vitro drug release: 
UV analysis 
In-vitro release studies were performed on the zinc and β-carotene loaded 
nanoparticles in gastric and intestinal mediums. Figures 4-15 and 4-16 
summarize the release profile of the sample in both mediums at different 
time intervals.  
Figure 4-14. Vitamin D3 [22] 
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Figure 4-15. β-carotene release profile in gastric fluid from B-carotene and 
zinc loaded nanoparticles 
Figure 4-15 shows the amount of β-carotene releases from zinc and β-
carotene loaded nanoparticles in gastric simulated fluid at pH 2. It is clear 
from the figure that about 33 % from total β-carotene is released in the 
gastric fluid after 2 hours. This can be attributed to the presence of pepsin 
enzymes, which hydrolyze the peptide bonds between amino acids thus 
releasing the β-carotene. It is also important to note that subjecting whey 
protein nanoparticles to very low pH values (~2) may result in significant 
electrostatic repulsion between protein strands which may subsequently lead 
to dissociation and disruption of the protein structure making up the 
nanoparticles.  
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Figure 14-16 shows the release profile in intestinal fluid. However, β-
carotene released at the first two hours was around 30%, reaching a 
maximum after 8 hours (70%) then moving to a plateau till 16 hrs.   Starting 
16 hrs, the drug started to degrade because as mentioned earlier in the HPLC 
results, the β-carotene moiety is very susceptible to autoxidation reactions 
that will lead to formation of biologically ineffective by-products, this 
explains the drop in Beta-carotene concentration found in intestinal fluid 
after 16 hrs.  The presence of trypsin enzymes in the simulated intestinal 
fluid most likely led to the denaturing of the whey protein nanoparticles and 
the subsequent β-carotene release. Interestingly, the amount released after 2 
hours in simulated gastric fluid was almost the same as that in the intestinal 
fluid (~30 %), which suggests that the main factor that controls β-carotene 
release is the presence of proteo-lytic enzymes (either Pepsin in gastric fluid 
or Trypsin in intestinal fluid).  In the intestinal fluid, maximum release was 
observed after 8 hours where 70 % of loaded β-carotene was released, but 
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Figure 4-16. β-carotene release profile from B-carotene and zinc whey 
protein nanoparticles in intestinal fluid. 
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the maximum release (around 33%) in gastric fluid was observed after 30 
minutes. 
 The change in pH, on the other hand, (from ~ 2 in the simulated gastric 
fluid to 7.4 in the simulated intestinal fluid) was shown not to affect the drug 
release profile for the drug at least for the first two hours.  
Almost the same release profile results were obtained by Jiang et al, which 
confirm that whey protein isolate nanoparticles are good carriers to deliver 
β-carotene as they exhibit low release profiles in gastric fluids and high 
release profile in intestinal fluids, although they prepared the whey protein 
nanoparticles by different method than those used here. [28] 
These results are of great advantage as the main site for β-carotene 
absorption in humans is in intestine through the intestinal mucosa, thus 
being able to survive harsh gastric conditions (i.e. very low pH in the 
presence of pepsin) and also being able deliver up to 70% of total β-carotene 
loaded in the nanoparticles to this site means that whey-protein nanoparticles 
can work as a good delivery vehicle for β-carotene. This conclusion is 
confirmed by the result of the Encapsulation efficiency which shows that 
97.8 % of drug added was successfully trapped in the nanoparticles.  
 
4.7. Atomic absorption 
Atomic absorption measurements, performed to assess the amount of zinc 
that was able to bind to the negatively charged groups in whey protein 
nanoparticles during the pH cycle, and it showed that 33% of the zinc ions 
were attached to the nanoparticles. Such a low binding percentage may be 
explained by the presence of significantly higher calcium concentration 
~2.25 mM (which part of it will participate in the formation of whey protein 
nanoparticles), relative to that of Zn which is 0.25 mM, and both ions will 
compete to bind to the negatively charged groups in protein amino acids, the 
Moreover, a research conducted by Eslam et al, had confirmed that the 
binding energy of calcium  to di –peptide proteins like carnosine (ΔH°298= -
187) is higher than that of Zinc (ΔH°298= -104) in solution phase [43], and as 
long as  the main protein present in whey is also a di-peptide protein (β-
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lactoglobulin), this may explain the low binding percentage of Zinc to whey 
protein particles.  
 
Chapter 5. Conclusion and future work: 
5.1. Conclusion 
Whey which is the liquid by-product produced during cheese-making is 
recognized nowadays as one of the most nutritious and valuable milk 
components. Whey protein isolate (WPI) is derived from whey through 
extensive purified process, and it contains biologically active proteins (i.e. 
alpha-lactalbumin (ALA), beta-lactoglobulin (BLG), bovine serum albumin 
(BSA), and immune-globulins (IgG)), that can act as immune-modulator and 
antibacterial agent. Whey protein exerts superior emulsification and gelling 
properties, as β- lactoglobulin (most abundant protein in WPI) which a very 
effective gelling property it can be used as pH-sensitive hydrogels for the 
controlled delivery of biologically-active substances. Thus, whey protein 
isolate is used to make nanoparticles to encapsulate sensitive bio-active 
ingredients like β-carotene to protect it and decrease its rate of auto-
oxidation reactions. β- carotene is an unsaturated hydrocarbon that shows a 
very potent anti-oxidant activity, by quenching singlet molecular oxygen and 
free radicals. Thus, β-carotene can reduce the risk of different diseases that 
are related to cells damage such as cancer, cardiovascular diseases, 
photosensitivity and aged-linked disorders. However, Zinc metal ion is 
classified as a potent antioxidant and also it has a role in β-carotene (pro-
vitamin A) metabolism, including its absorption, transport, and utilization. It 
is therefore recommended to combine zinc ions with β-carotene 
supplementation.  
Whey protein nanoparticles incorporating β-carotene and zinc is thus 
formulated to be used in food formulation as well as pharmaceutical 
preparation. These loaded nanoparticles were prepared by pH cycle method 
at aggregation pH 6 and 22 hours ageing time. The particles were then 
characterized using zeta sizer, SEM, FT-IR techniques. In addition, the 
stability of the loaded β-carotene and the release behavior at acidic and 
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neutral conditions were assessed using HPLC and UV spectrometer. Amount 
of zinc ions loaded also were calculated using atomic absorption.      
Indeed, the results showed that around 97 % of β-carotene and 33% of zinc 
ions originally added to the formulation were successfully encapsulated in 
the whey protein nanoparticles, and 70% of the loaded β-carotene were 
released in the intestinal fluid. Also, the release study revealed that whey 
protein nanoparticles are hydrolyzed only in the presence proteo-lytic 
enzymes (pepsin and trypsin), as changing the pH didn’t affect the release 
performance of whey protein nanoparticles. However, the stability of the β-
carotene loaded in nanoparticles was higher than the control sample (β-
carotene in water-ethanol mixture) after storage at same conditions for 7 
days. 
The SEM images have confirmed that the formulated nanoparticles are 
spherical in shape while the zeta sizer have showed that they are of around 
400 nm in diameter. In general, the results obtained recommend usage of 
whey protein nanoparticles for encapsulation and drug delivery purposes in 
food and pharmaceutical industries.  
5.2. Future work: 
Future work should focus on the following; 
 In-vitro antioxidant activity evaluation for the released beta-carotene.   
 The use of whey protein nanoparticles for encapsulation of other 
hydrophobic nutritive ingredients, as this will hopefully allow their 
incorporation in any food and/or pharmaceutical formulation with 
acceptable release properties.  
 Studying the effect of adding other metal ions on the aggregation 
behavior of whey protein nanoparticles.  
 Sensory evaluation for the loaded whey protein nanoparticles to 
ensure that they will not have any impact on the sensory attributes of 
their final application.  
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Appendix : Calibration curves 
 
Calibration curve of β carotene (HPLC) 
 
Calibration curve of β-carotene in Dichloromethane (DCM) 
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Calibration curve of β-carotene in simulated intestinal fluid. 
 
Calibration curve of Zinc 
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Calibration curve of β-carotene in hexane 
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